ArticleIDCases2026
Serologically supported pediatric brucellosis presenting with marked conjugated hyperbilirubinemia and marked systemic inflammation: A case report.
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brucellosis is a multisystem zoonosis that can mimic complicated bacterial infection in children. A 10-year-old girl presented with prolonged high-grade fever, jaundice, abdominal pain, anorexia and weight loss. The initial syndrome was managed empirically as an undifferentiated complicated bacterial illness because enteric fever and a hepatobiliary or intra-abdominal source were considered. CRP was 333.2 mg/L and total/direct bilirubin 7.24/5.21 mg/dL despite only mild aminotransferase elevation; ultrasonography showed hepatomegaly and nonspecific gallbladder-wall edema without biliary dilatation or focal lesions. CRP peaked at 407.1 mg/L and began falling during meropenem-linezolid therapy before Brucella-directed treatment, so biomarker response was not used diagnostically. Re-taking the history revealed daily consumption of unboiled dairy milk for several months. On hospital day 6, doxycycline, rifampicin and gentamicin were started simultaneously, with discontinuation of meropenem and linezolid. Brucella serology was concordant: a laboratory-reported agglutination result labelled B. melitensis was reactive at 1:80 and later EIA showed strongly positive IgM and IgG, but neither test established species identity and culture/PCR confirmation was not obtained. Fever resolved by hospital day 14. At immediate post-treatment follow-up on 8 September 2026, she remained clinically well; weight had increased from 19 to 20 kg, CRP was 1.2 mg/L, total/direct bilirubin 0.8/0.2 mg/dL, AST/ALT 34/43 IU/L and alkaline phosphatase 417 U/L (within a published pediatric reference interval), with renal function within the laboratory reference range. Hemoglobin had improved to 7.8 g/dL with persistent microcytosis, before oral iron supplementation was initiated. The diagnosis is therefore best regarded as serologically supported pediatric brucellosis rather than microbiologically confirmed disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.